Categories: Top News

Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2023, and projected year end 2023 cash, cash equivalents, and restricted cash balance, which remain subject to quarter end closing adjustments and are also unaudited.

GlobeNewswire

GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Recent Posts

UPDATE — Opreme Films announces “Just Blood”: A Medical Demonstration Poised to Rewrite Theranos Story

Ryan El-Hosseiny Declares Elizabeth Holmes Was Right All Along—And Plans to Prove It Live! Just…

2 hours ago

SHEIN brings Timeless Chic & Cosy Aussie Style to Sydney

The Café SHEIN FW25 Pop-Up to Take Over Parramatta this MaySYDNEY, April 22, 2025 (GLOBE…

4 hours ago

Farmers Driving Change This Earth Day by Recycling on the Farm

Used ag plastic jugs ready to be collected and recycled by Cleanfarms Farmers' efforts in…

4 hours ago

Notre Dame de Namur University Announces Supervisor Jackie Speier as Keynote Speaker for 173rd Commencement Ceremony

BELMONT, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Notre Dame de Namur University (NDNU), the…

4 hours ago

This website uses cookies.